Sentinel lymph node detection and imaging

European Journal of Nuclear Medicine

Volumn 26, Issue 1, 1999, Pages 57-67

  Keshtgar, M R S ^a   Ell, P J ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOPHARMACEUTICAL AGENT;

BREAST CANCER; CANCER SURGERY; HUMAN; LYMPH NODE; PATIENT SELECTION; REVIEW; SENTINEL LYMPH NODE;

BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; MALE; MELANOMA; NEOPLASM STAGING; RADIOPHARMACEUTICALS; SKIN NEOPLASMS;

EID: 0033018172     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050360     Document Type: Review

References (28)

1. 1. Dixon M. Sentinel node biopsy in breast cancer. Br Med J 1998; 317: 295-296.
2. 2. della Rovere G, Bird PA. Sentinel-lymph-node in breast cancer. Lancet 1998; 352: 421-422.
3. 3. Borgstein PJ. SLN biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-283.
4. 4. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida ST, Bodeni N, Costa A, Chicco C, Geraghty JG, Luine A, Sacchini V, Veronesi P. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinicaly negative lymph-nodes. Lancet 1997; 349: 1864-1867.
5. 5. Kinmonth JB. Lymphangiogram in man: method outlining lymphatic trunks and operation. Clin Sci 1952; 11: 13-20.
6. 6. Sherman A, Ter-Pogossian M. Lymph node concentration of radioactive colloid gold following insterstitial injection. Cancer 1953; 6: 1238-1240.
7. 7. Turner-Warrick R. The demonstration of lymphatic vessels. Lancet 1955; 1: 1371.
8. 8. Hultborn KA, Larsson LG, Ragnhult I. The lymph drainage from the breast to the axillary and parasternal lymph node: studied with the help of Au-198. Acta Radiol 1955; 43: 52-64.
9. 9. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, Renwick SB. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36: 1775-1780.
10. 10. Garzom OL, Palcos MC, Radicella R. Technetium-99m labelled colloid. Int J Appl Radiat Isotopes 1965; 16: 613.
11. 11. Strand S-E, Persson DRR. Quantitative lymphoscintigraphy. I. Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 1979; 1038-1046.
12. 12. Bergqvist L, Srand SE, Persson B, Hafstrom L, Jonsson PE. Dosimetry in lymphoscintigraphy of &c-99m antimony sulfide colloid. J Nucl Med 1982; 23: 698-705.
13. 13. Kaplan WD, Davies MA, Rose CHN. A comparison of two technetium-99m labelled radiopharmaceuticals for lymphoscintigraphy: concise communication. J Nucl Med 1979; 20: 933-937.
14. 14. Paganelli G, Chicco C, Cremonesi M, Prisco G, Calza P, Luini A, Zucali P, Veronesi U. Optimised sentinel node scintigraphy in breast cancer. Q J Nucl Med 1998; 42: 49-53.
15. 15. Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med 1998; 39: 1185-1190.
16. 16. Tiourina T, Arends B, Huysmans D, Rutten H, Lemaire B, Muller S. Evaluation of surgical gamma probes for radioguided sentinel node localisation. Eur J Nucl Med 1998; 25: 1224-1231.
17. 17. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathological validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226: 271-278.
18. 18. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. J Am Med Assoc 1996; 276: 1818-1822.
19. 19. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS. Guidelines for SN biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227: 645-653.
20. 20. Morton DL, Wen D-R, Wong GH, et al. Technical details of intra-operative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
21. 21. Slingluff, CL Jr., Stidham KR, Ricci WM, Stanley WE, Seigler HF. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4,682 patients. Ann Surg 1994; 219: 120-130.
22. 22. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, Heller R, Ross M, Lyman G, Cox C, Rappaport D, Seigler HF, Balch C. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220: 759-767.
23. 23. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, Berman CG, Jared K, Messina J, Lyman G, Glass F, Fenske N, Reintgen DS. Intraoperutive radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217-224.
24. 24. Leong SPL, Steinmetz I, Habib FA, McMillan A, Gans JZ, Allen RE Jr., Morita E, El-Kadi M, Epstein HD, Kashani-Sabet M, Sagebiel RW. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1998; 132: 666-673.
25. 25. Joseph E, Brobeil A, Glass F, Glass J, Messina J, DeConti R, Cruse CW, Rapaport DP, Berman C, Fenske N, Reintgen DS. Results of complete lymph node dissection in 83 melanoma patients with positive SLN. Ann Surg Oncol 1998; 5: 119-125.
26. 26. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Imme diate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 1998; 351: 793-796.
27. 27. Tortora GJ, Reynolds Grabowski S. Principles of anatomy and physiology, 8th ed. Addison Wesley Longman, 1996
28. 28. Hayes DF. Atlas of breast cancer. Mosby, 1993